Pfizer's chief scientist Mikael Dolsten to step down
Dolsten, aged 65, served as the head of Pfizer's research and development after he joined the company through its $68 billion acquisition of Wyeth in 2009. During his tenure, Comirnaty — jointly ...
Reuters via Yahoo
1 day ago